PTPRG, protein tyrosine phosphatase receptor type G, 5793
N. diseases: 70; N. variants: 19
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
3 | 61808380 | intron variant | C/A;T | snv |
|
0.800 | 1.000 | 1 | 2009 | 2009 | |||||||||||
|
1.000 | 0.080 | 3 | 61650482 | intron variant | G/T | snv | 0.17 |
|
Nervous System Diseases; Mental Disorders | 0.710 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.080 | 3 | 62051050 | intron variant | C/T | snv | 0.13 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.040 | 3 | 61634560 | intron variant | A/T | snv | 9.7E-02 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.040 | 3 | 61634560 | intron variant | A/T | snv | 9.7E-02 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 62132816 | intron variant | G/T | snv | 0.13 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
3 | 61864416 | intron variant | G/A | snv | 2.3E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 61792590 | intron variant | T/G | snv | 8.7E-02 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
3 | 62115166 | intron variant | T/C | snv | 0.75 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 3 | 62138804 | intron variant | G/A;C | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
3 | 62126524 | intron variant | T/C | snv | 0.79 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
3 | 61790134 | intron variant | A/T | snv | 0.15 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
1.000 | 0.040 | 3 | 62131511 | intron variant | T/G | snv | 0.44 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 3 | 61963062 | intron variant | G/A | snv | 0.11 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 3 | 61963062 | intron variant | G/A | snv | 0.11 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
3 | 62160398 | intron variant | G/C | snv | 9.9E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
3 | 61572044 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
3 | 61572044 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
1.000 | 0.080 | 3 | 62153280 | intron variant | C/G | snv | 4.7E-02 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
3 | 62008030 | intron variant | G/T | snv | 0.39 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.080 | 3 | 62203515 | missense variant | G/A | snv | 0.19 | 0.16 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.925 | 0.080 | 3 | 62203515 | missense variant | G/A | snv | 0.19 | 0.16 |
|
0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 3 | 62047679 | intron variant | C/T | snv | 0.12 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 3 | 62047679 | intron variant | C/T | snv | 0.12 |
|
0.010 | 1.000 | 1 | 2014 | 2014 |